Abstract:Background: Disrupted intestinal epithelial barrier is one of the major causes of Crohn's disease (CD). Novel molecular targets for intestinal epithelial barrier are essential to treatment of CD. Transmembrane and immunoglobulin domain-containing protein 1 (TMIGD1) is an adhesion molecule that regulates cell adhesion, migration, and enterocyte differentiation. However, the function and mechanism of TMIGD1 in CD and intestinal epithelial barrier has rarely been studied. Furthermore, the association between TMIGD1 and the clinical features of CD remains unclear. Methods: Transcriptome analysis on colonic mucosa from CD patients and healthy individuals were performed to identify dysregulated genes. Multi-omics integration of the 1000IBD cohort including genomics, transcriptomics of intestinal biopsies, and serum proteomics identified the association between genes and characteristics of CD. Inflammation was assessed by cytokine production in cell lines, organoids and intestinal-specific Tmigd1 knockout (Tmigd1INT-KO) mice. Epithelial barrier integrity was evaluated by trans-epithelium electrical resistance (TEER), paracellular permeability, and apical junction complex (AJC) expression. Co-immunoprecipitation, GST pull-down assays, mass spectrometry, proteomics, and transcriptome analysis were used to explore downstream mechanisms. Results: Multi-omics integration suggested that TMIGD1 was negatively associated with inflammatory characteristics of CD. TMIGD1 was downregulated in inflamed intestinal mucosa of patients with CD and mice colitis models. Tmigd1INT-KO mice were more susceptible to chemically induced colitis. In epithelial cell lines and colonic organoids, TMIGD1 knockdown caused impaired intestinal barrier integrity evidenced by increased paracellular permeability and reduced TEER and AJC expression. TMIGD1 knockdown in intestinal epithelial cells also induced pro-inflammatory cytokine production. Mechanistically, TMIGD1 directly interacted with cytoplasmic BAF nuclear assembly factor 1 (BANF1) to inhibit NF-κB activation. Exogenous expression of TMIGD1 and BANF1 restored intestinal barrier function and inhibited inflammation in vitro and in vivo. TMIGD1 expression predicted response to anti-TNF treatment in patients with CD. Conclusions: Our study demonstrated that TMIGD1 maintained intestinal barrier integrity and inactivated inflammation, and was therefore a potential therapeutic target for CD.

FoxO1 regulates TLR4/MyD88/MD2-NF-κB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease.

FoxO 4 Inhibits NF-κ B and Protects Mice Against Colonic Injury and Inflammation

Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis

TL1A Modulates the Severity of Colitis by Promoting Th9 Differentiation and IL-9 Secretion.

Histone Acetyltransferase Mof Affects the Progression of DSS-Induced Colitis

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

[Changes in Tight Junction Protein Expression and Permeability of Colon Mucosa in Rats with Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease].

Tu1742 Oxazolone Induced Rat Colitis by a Mast Cell-Dependent Mechanism

Tlr4 regulates IFNγ and IL-17 production by both natural and induced Foxp3+ Tregs in the inflamed intestine during intestinal inflammation (P3276)

The Study of Expression and Mechanism of Foxp3 on TNBS-induced Colitis in Rats

The Protective Role of TLR4 in Intestinal Epithelial Cells through the Regulation of the Gut Microbiota in DSS-Induced Colitis in Mice

MicroRNA‐9a‐5p‐NOX4 inhibits intestinal inflammatory injury by regulating the M1 polarization of intestinal macrophages

Th1 Promotes M1 Polarization of Intestinal Macrophages to Regulate Colitis-Related Mucosal Barrier Damage.

Protective role of tumor necrosis factor (TNF) receptors in chronic intestinal inflammation: TNFR1 ablation boosts systemic inflammatory response

Opposite Role Of Tumor Necrosis Factor Receptors In Dextran Sulfate Sodium-Induced Colitis In Mice

Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model

Inhibition of Myeloid Differentiation 1 Specifically in Colon with Antisense Oligonucleotide Exacerbates Dextran Sodium Sulfate-Induced Colitis

Upregulated Tβ4 expression in inflammatory bowel disease impairs the intestinal mucus barrier by inhibiting autophagy in mice

Galactooligosaccharides Protects Against DSS-induced Murine Colitis Through Regulating Intestinal Flora and Inhibiting NF-κB Pathway.

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease

TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice